Neil Devani

Neil Devani is the Founder and Managing Partner of Necessary Ventures, an early-stage venture capital firm that invests $250,000 to $500,000 in pre-seed companies. He holds a Bachelor of Science from Pennsylvania State University, attended medical school at Drexel University College of Medicine, and earned a Juris Doctor from Stanford Law School. As an early investor, Devani backed companies that successfully reached the public markets, including AI drug discovery firm Recursion Pharmaceuticals and robotics company Vicarious Surgical, where he served as the first investor and a board director. He currently holds board seats at Plural, OneImaging, and Rubi Laboratories, while also advising Upsolve, a nonprofit organization that has cleared over $1 billion in medical debt. His investment strategy primarily focuses on deep technology and artificial intelligence applications across the healthcare, climate, financial services, and reindustrialization sectors.